Canon / Norton / International Letrozole Breast Cancer Group / Dimitrov NV / /
IndustryTerm
therapy of advanced breast cancer / therapy for breast cancer / treatment of breast cancer / therapy for operable breast cancer / /
MedicalCondition
oestrogen receptor-positive breast cancer / hormone receptor positive tumours / HER2+ breast cancer / rapidly proliferating breast cancer / tumor / node-positive breast cancer / HER2 positive breast cancer / hormone sensitive breast cancer / cancer / hormone receptor positive breast cancer / primary breast cancer / positive-node breast cancer / Clin Breast Cancer / estrogen receptor-positive breast cancer / early breast cancer / node-negative breast cancer / tumour / Early stage lymph node positive breast cancer / estrogen-receptorpositive tumors / J Cancer / adjuvant breast cancer AND / hormone receptor-positive breast cancer / tamoxifen-nonresponsive tumors / invasive breast cancer / Metastatic breast cancer / LN negative disease / operable breast cancer / HER2positive breast cancer / Hormone receptor negative disease / LN+ breast cancer / HER2-positive breast cancer / multidisciplinary breast cancer / advanced breast cancer / BREAST CANCER / earlystage breast cancer / /
Breast Cancer Trials Committee / African Union / Nolvadex' Adjuvant Trial Organisation / Scottish Cancer Trials Office / Alberta Provincial Breast Tumour Team / American Society of Clinical Oncology / Guideline Utilization Resource Unit / /
Person
Raina V / /
Position
Muss HB / Fisher / General / Knowledge Management Specialist / /
Adjuvant Systemic Therapy Version 1 Adjuvant Systemic Therapy for Early Stage (Lymph Node Negative and Lymph Node Positive) Breast Cancer